(Q48100322)

8 February 2018

title

T2 hypointense rims and ring-enhancing lesions in MS. (English)

1 reference

8 February 2018

author

Sara Llufriu

1

1 reference

8 February 2018

Albert Saiz

9

1 reference

8 February 2018

Pablo Villoslada

object named as

Pablo Villoslada

7

0 references

Francesc Graus

object named as

Francesc Graus

8

1 reference

ORCID Public Data File 2021

author name string

Teresa Pujol

2

1 reference

8 February 2018

Yolanda Blanco

3

1 reference

8 February 2018

Karolina Hankiewicz

4

1 reference

8 February 2018

Mattia Squarcia

5

1 reference

8 February 2018

Joan Berenguer

6

1 reference

8 February 2018

publication date

4 August 2010

1 reference

8 February 2018

Multiple Sclerosis Journal

published in

1 reference

8 February 2018

volume

16

1 reference

8 February 2018

issue

11

1 reference

8 February 2018

page(s)

1317-1325

1 reference

8 February 2018

Persistence of immunopathological and radiological traits in multiple sclerosis.

cites work

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Pattern of T2 hypointensity associated with ring-enhancing brain lesions can help to differentiate pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Diffusion of water in large demyelinating lesions: a follow-up study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Diffusion MRI in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Prevalence of restless legs syndrome and REM sleep behavior disorder in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Direct and indirect costs of Multiple Sclerosis in Baix Llobregat (Catalonia, Spain), according to disability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Characterization of tumefactive demyelinating lesions using MR imaging and in-vivo proton MR spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Iron deposits in multiple sclerosis and Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

High field MRI in the diagnosis of multiple sclerosis: high field-high yield?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Quantitative in vivo magnetic resonance imaging of multiple sclerosis at 7 Tesla with sensitivity to iron

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

MRI characteristics of atypical idiopathic inflammatory demyelinating lesions of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Inflammatory central nervous system demyelination: correlation of magnetic resonance imaging findings with lesion pathology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Predictive value of gadolinium-enhanced magnetic resonance imaging for relapse rate and changes in disability or impairment in multiple sclerosis: a meta-analysis. Gadolinium MRI Meta-analysis Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Persistent T1 hypointensity as an MRI marker for treatment efficacy in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Enhancing magnetic resonance imaging lesions and cerebral atrophy in patients with relapsing multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Acute and chronic changes of the apparent diffusion coefficient in neurological disorders--biophysical mechanisms and possible underlying histopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

Primary progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

MRI as an outcome in multiple sclerosis clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1352458510377905

21 January 2018

Identifiers

DOI

10.1177/1352458510377905

1 reference

8 February 2018

1 reference

8 February 2018